Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin-Assisted Psychotherapy for Gambling Disorder
NCT07391332Phase 2Recruiting
- Sponsor
- CHU de Nantes
- Start
- Oct 2026
- Primary completion
- Jul 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in gambling disorder (GD), sponsored by CHU de Nantes. Started Oct 2026; status: recruiting.
02
Drugs
psilocybin
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on NCT07391332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07391332.